WebPermeon Biologics, Inc. aims to enhance human health by using our novel Intraphilin Technology Platform to enable intracellular biologics as a revolutionary new generation of therapeutic drugs. VentureRadar Research / Company Website. Associated sectors: Health care; Cells; Similar Companies: AGR Health, LLC USA n/a Digital Health Care Payment ... WebJul 28, 2011 · Permeon Biologics, a biopharmaceutical company pioneering a novel class of intracellular protein biologics, today announced the discovery of an entirely new class of …
SEC FORM D
WebJul 28, 2011 · Permeon Biologics, a biopharmaceutical company pioneering a novel class of intracellular protein biologics, today announced the discovery of an entirely new class of naturally occurring human ... WebPermeon Biologics is developing a panel of human proteins that exhibit potent activity as Intraphilins for intracellular biologics in vivo. As part of developing intracellular biologics, Permeon's Intraphilin Technology Platform also enables functional proteins to replace or restore defective pathways inside cells that cause disease. itv drama stonehouse cast
Permeon Biologics Inc. - Company Profile - BCIQ
WebPermeon Biologics, Inc. Founded Date January 1, 2011 Total Funding Amount (USD) 2,500,000 Latest Funding Round Date December 30, 2011 Other attributes Country United States Headquarters Cambridge, Massachusetts Wikidata ID Q17085226 Company Operating Status Active Categories Company WebPermeon Biologics is pioneering a breakthrough class of intracellular biologics that target a broad spectrum of previously undruggable targets. Leveraging its Intraphilin(TM) Technology Platform exclusively licensed from Harvard University, the company's next-gener ation approach is being developed to unlock the full therapeutic potential of ... WebPermeon Biologics, Inc. is a US-based company that operates as a developer of Intraphilin Technology Platform to enable intracellular biologics as therapeutic drugs. Current … itv drama our house